Lactobacillus Rhamnosus.

Inulin passes human digestion intact and is fermented by lactic acid bacteria to lactate and short-chain fatty acids, lowering colonic pH. Strain plus substrate is the defining synbiotic pairing.

Partially hydrolysed guar gum ferments evenly along the colon and supports lactic acid bacteria without thickening a drink. It is the common carrier fibre in strain products.

Pectin is fermented to short-chain fatty acids and forms a gel that slows transit, giving organisms longer contact with substrate.

Oat beta-glucan reaches the colon undigested and is fermented by lactic acid bacteria, adding lactate substrate. Its upper-gut viscosity also slows transit of a co-dosed strain.

Rhamnosus produces lactate that butyrate-forming bacteria consume and convert onward, so the two metabolites sit in one cross-feeding chain. Supplying butyrate delivers the downstream end directly.

Glutamine is the main fuel of small intestinal cells and supports normal tight-junction protein expression, acting on the host side of the barrier. The strain works the luminal side of the same barrier.

Colostrum brings secretory immunoglobulins plus milk oligosaccharides that lactic acid bacteria ferment. The pairing is standard in gut-barrier formulations.

Lactic acid bacteria carry beta-galactosidase and hydrolyse some lactose themselves, the same substrate a supplemental lactase acts on. The two routes add together.

Carvacrol and thymol disrupt bacterial membranes indiscriminately, so a simultaneous dose cuts the viable count of a delivered strain. Doses are separated in practice.

Berberine acts directly on luminal bacteria and shifts community composition, which counters a live-organism dose given at the same time. Spacing them is the accepted approach.

Charcoal adsorbs organic molecules broadly, including the substrates a delivered strain needs in the lumen. Anything co-dosed with charcoal has to be spaced apart.

Lactobacilli ferment short-chain fructooligosaccharides to lactate and acetate, which is the definition of a synbiotic pairing. Supplying substrate alongside the organism is standard formulation practice. Which strains benefit most from which chain length is strain-specific and not settled.

Galactooligosaccharides are fermented by lactobacilli and bifidobacteria and resist digestion in the small intestine, so they arrive intact where the organisms are. The pairing supplies substrate and organism together. As with any prebiotic, gas and bloating on introduction is the common tolerance limit.

Resistant starch escapes amylase digestion and is fermented in the colon, feeding the microbial community that a probiotic joins. The direct fermenters of resistant starch are mostly other genera, with lactobacilli benefiting through cross-feeding on the products. That indirect route is why this sits at Strong rather than Established.

Bifidobacteria and lactobacilli occupy different parts of the gut and ferment different substrate ranges, and bifidobacterial fermentation products feed lactate-consuming butyrate producers downstream. Multi-strain formulas pair them for that complementarity. Species-level pairing does not guarantee a strain-level result.

The two species are routinely blended in multi-strain products because they differ in bile tolerance, adhesion and fermentation range. Blending broadens the conditions under which at least some of the dose survives transit. Evidence for a blend is not the sum of evidence for its parts.

Saccharomyces boulardii is a yeast, so agents that suppress bacteria do not suppress it. Pairing it with a bacterial strain means the formula retains a viable organism under conditions where lactobacilli would be knocked back. The two act by different routes and are not interchangeable.

Milk protein raises the pH of the stomach contents and physically shields organisms during transit, which is why fermented dairy is a classic delivery vehicle for lactobacilli. Taking a probiotic with a protein-containing meal applies the same principle. The effect is on survival through the stomach, not on what the organism does afterwards.

Gastric acid is the main cause of viable count loss between swallowing and the small intestine. Buffering the stomach transiently reduces that loss. This is why some products use enteric coating instead, and either approach addresses survival rather than efficacy.

Betaine hydrochloride is taken specifically to lower stomach pH, which is the condition that kills the most probiotic organisms in transit. Taking the two at the same moment works against the probiotic. Separating them by an hour or more is the practical handling.

Allicin and related organosulfur compounds from garlic have broad antibacterial activity in vitro that includes lactobacilli. Concentrated garlic extracts taken simultaneously may reduce the viable dose that survives. The interaction is documented in vitro and its size in the gut is not established.

Bentonite adsorbs onto surfaces non-selectively, and a bacterial cell is a surface. Taking an adsorbent at the same time as a live organism risks binding part of the dose. Separating the two in the day is the ordinary handling for any adsorbent.

Lactoferrin sequesters iron, which restrains iron-dependent organisms while lactobacilli, which have unusually low iron requirements, are comparatively unaffected. That selectivity is why lactoferrin appears in infant and gut formulas alongside lactobacilli. The mechanism is well characterised in vitro; in vivo magnitude is not.

Psyllium is only partially fermented, but it slows transit and holds water in the colon, changing the environment an introduced organism arrives in. It is less a direct food source than a habitat change. That distinction is why this sits below the oligosaccharide pairings.

Konjac glucomannan is fermented in the colon to short-chain fatty acids, contributing substrate to the resident community. Its viscosity also slows gastric emptying, which changes probiotic transit conditions. Neither effect has been measured with this species specifically.

Zinc is required for the tight junction protein expression that maintains normal intestinal barrier function, an endpoint probiotic strains are also studied against. The two arrive at the same measure from unrelated directions. No combination work supports the pairing directly.

Vitamin D receptor signalling in intestinal epithelium influences antimicrobial peptide expression and barrier proteins, overlapping with the mucosal measures probiotic strains are studied on. The overlap is at the level of shared endpoints. Labelled Early because nothing measures the two together.

Gut bacteria convert catechins into smaller phenolic metabolites that absorb differently from the parent compounds, and catechins in turn have antibacterial activity in vitro that varies by organism. The relationship runs both ways and is not settled for this species. Included so a formulator sees the interaction rather than assuming none.